Daniele Generali

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Venues

Cancers

Cells

International journal of molecular sciences

Biomedicines

AO Istituti Ospitalieri di Cremona

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AO Istituti Ospitalieri di Cremona Sep 02 2000

Italy

Head :: SS Terapia Molecolare e Farmacogenomica

Publications

Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda Losada, Stefano Panni, Marika Cominetti, Patrizia D'Auria, Simonetta Bianchini, Elena Varotti, Marco Ungari, Stefano Ciccarelli, Marzia Filippini, Sarah Brenna, Valentina Fiori, Tomas Di Mambro, Angelo Sparti, Mauro Magnani, Fabrizio Zanconati, Daniele Generali, Antonio Fioravanti
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study. Cells 13 (7) (2024)
Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda Losada, Stefano Panni, Marika Cominetti, Patrizia D'Auria, Simonetta Bianchini, Elena Varotti, Marco Ungari, Stefano Ciccarelli, Marzia Filippini, Sarah Brenna, Valentina Fiori, Tomas Di Mambro, Angelo Sparti, Mauro Magnani, Fabrizio Zanconati, Daniele Generali, Antonio Fioravanti
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study. Cells 13 (7) (2024)
Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda Losada, Stefano Panni, Marika Cominetti, Patrizia D'Auria, Simonetta Bianchini, Elena Varotti, Marco Ungari, Stefano Ciccarelli, Marzia Filippini, Sarah Brenna, Valentina Fiori, Tomas Di Mambro, Angelo Sparti, Mauro Magnani, Fabrizio Zanconati, Daniele Generali, Antonio Fioravanti
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study. Cells 13 (7) (2024)
Navid Sobhani, Alberto D'Angelo, Matteo Pittacolo, Giuseppina Mondani, Daniele Generali
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion. Cancers 16 (17) (2024)
Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda Losada, Stefano Panni, Marika Cominetti, Patrizia D'Auria, Simonetta Bianchini, Elena Varotti, Marco Ungari, Stefano Ciccarelli, Marzia Filippini, Sarah Brenna, Valentina Fiori, Tomas Di Mambro, Angelo Sparti, Mauro Magnani, Fabrizio Zanconati, Daniele Generali, Antonio Fioravanti
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study. Cells 13 (7) (2024)
Maria Loreta Libero, Antonio J Montero-Hidalgo, Lucia Recinella, Raul Miguel Luque, Daniele Generali, Alessandra Acquaviva, Giustino Orlando, Claudio Ferrante, Luigi Menghini, Simonetta Cristina Di Simone, Nilofar Nilofar, Annalisa Chiavaroli, Luigi Brunetti, Sheila Leone
The Protective Effects of an Aged Black Garlic Water Extract on the Prostate. Nutrients 16 (17) (2024)
Marina Bortul, Fabiola Giudici, Domenico Tierno, Daniele Generali, Serena Scomersi, Gabriele Grassi, Cristina Bottin, Maria Rosa Cappelletti, Fabrizio Zanconati, Bruna Scaggiante
A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection. International journal of molecular sciences 24 (10) (2023)
Giulia Ottaviani, Giada Targato, Katia Rupel, Margherita Gobbo, Daniele Generali, Alessandra Guglielmi, Angela Dicorato, Daniela Adamo, Federica Canfora, Roberto Di Lenarda, Matteo Biasotto
Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational Study. Cancers 16 (1) (2023)
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, Andrea Rocca, Alberto D'Angelo, Fabiola Giudici, Cristina Bottin, Carmine Antonio Donofrio, Maurizio Pinamonti, Benvenuto Ferrari, Stefano Panni, Marika Cominetti, Jahard Aliaga, Marco Ungari, Antonio Fioravanti, Fabrizio Zanconati, Daniele Generali
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report. Biomedicines 11 (2) (2023)
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, Andrea Rocca, Alberto D'Angelo, Fabiola Giudici, Cristina Bottin, Carmine Antonio Donofrio, Maurizio Pinamonti, Benvenuto Ferrari, Stefano Panni, Marika Cominetti, Jahard Aliaga, Marco Ungari, Antonio Fioravanti, Fabrizio Zanconati, Daniele Generali
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report. Biomedicines 11 (2) (2023)
Monica Ganzinelli, Federica Guffanti, Anna Ianza, Navid Sobhani, Sergio Crovella, Fabrizio Zanconati, Cristina Bottin, Marco Confalonieri, Stefano Fumagalli, Alessandra Guglielmi, Daniele Generali, Giovanna Damia
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair. Cancers 15 (17) (2023)
Giulia Ottaviani, Giada Targato, Katia Rupel, Margherita Gobbo, Daniele Generali, Alessandra Guglielmi, Angela Dicorato, Daniela Adamo, Federica Canfora, Roberto Di Lenarda, Matteo Biasotto
Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational Study. Cancers 16 (1) (2023)
Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, Andrea Rocca, Alberto D'Angelo, Fabiola Giudici, Cristina Bottin, Carmine Antonio Donofrio, Maurizio Pinamonti, Benvenuto Ferrari, Stefano Panni, Marika Cominetti, Jahard Aliaga, Marco Ungari, Antonio Fioravanti, Fabrizio Zanconati, Daniele Generali
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report. Biomedicines 11 (2) (2023)
Domenico Tierno, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati, Bruna Scaggiante
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. International journal of molecular sciences 24 (11) (2023)
Andrea Rocca, Luca Braga, Maria Concetta Volpe, Serena Maiocchi, Daniele Generali
The Predictive and Prognostic Role of RAS-RAF-MEK-ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets. Cancers 14 (21) (2022)
Francesco Salton, Paola Confalonieri, Giuseppina Campisciano, Rossella Cifaldi, Clara Rizzardi, Daniele Generali, Riccardo Pozzan, Stefano Tavano, Chiara Bozzi, Giulia Lapadula, Gianfranco Umberto Meduri, Marco Confalonieri, Manola Comar, Selene Lerda, Barbara Ruaro
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS. Journal of clinical medicine 11 (11) (2022)
Francesco Pavese, Ettore Domenico Capoluongo, Margherita Muratore, Angelo Minucci, Concetta Santonocito, Paola Fuso, Paola Concolino, Enrico Di Stasio, Luisa Carbognin, Giordana Tiberi, Giorgia Garganese, Giacomo Corrado, Alba Di Leone, Daniele Generali, Simona Maria Fragomeni, Tatiana D'Angelo, Gianluca Franceschini, Riccardo Masetti, Alessandra Fabi, Antonino Mulè, Angela Santoro, Paolo Belli, Giampaolo Tortora, Giovanni Scambia, Ida Paris
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers 14 (19) (2022)
Navid Sobhani, Richard Chahwan, Raheleh Roudi, Rachel Morris, Stefano Volinia, Dafei Chai, Alberto D'Angelo, Daniele Generali
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer. Cancers 14 (12) (2022)
Sunil S Badve, Sanghee Cho, Xiaoyu Lu, Sha Cao, Soumya Ghose, Aye Aye Thike, Puay Hoon Tan, Idris Tolgay Ocal, Daniele Generali, Fabrizio Zanconati, Adrian L Harris, Fiona Ginty, Yesim Gökmen-Polar
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast. Cancers 14 (16) (2022)
Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro, Fabio Puglisi, PierFranco Conte, Michelino De Laurentiis, Lajos Pusztai, Mothaffar F Rimawi, Rachel Schiff, Grazia Arpino, Sabino De Placido, Aleix Prat, Daniele Generali
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis. Cancers 13 (6) (2021)
Navid Sobhani, Dana Rae Tardiel-Cyril, Aram Davtyan, Daniele Generali, Raheleh Roudi, Yong Li
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers 13 (6) (2021)
Navid Sobhani, Anne Fassl, Giuseppina Mondani, Daniele Generali, Tobias Otto
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer. Cells 10 (2) (2021)
Ottavia Bernocchi, Marianna Sirico, Silvia Paola Corona, Carla Strina, Manuela Milani, Maria Rosa Cappelletti, Giuseppina Ferrero, Nicoletta Ziglioli, Valeria Cervoni, Andrea Macchiavelli, Giandomenico Roviello, Daniele Generali
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lüftner, Sylvie Rottey, Peter A van Dam, Khalil Zaman, Giorgio Mustacchi, Joseph Gligorov, Ahmad Awada, Mario Campone, Hans P M W Wildiers, Alessandra Gennari, Vivianne C G Tjan-Heijnen, Javier Cortes, Mariavittoria Locci, Ida Paris, Lucia Del Mastro, Sabino De Placido, Miguel Martin, Guy Jerusalem, Sergio Venturini, Curigliano Giuseppe, Daniele Generali
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer. Cancers 13 (17) (2021)
Navid Sobhani, Giandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, Praveen Kumar Neeli, Daniele Generali
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis. Molecules (Basel, Switzerland) 26 (20) (2021)
Sobhani Navid, Chunmei Fan, Pedro O Flores-Villanueva, Daniele Generali, Yong Li
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments. International journal of molecular sciences 21 (6) (2020)
Francesco Schettini, Navid Sobhani, Anna Ianza, Tiziana Triulzi, Alfredo Molteni, Maria Chiara Lazzari, Carla Strina, Manuela Milani, Silvia Paola Corona, Marianna Sirico, Ottavia Bernocchi, Fabiola Giudici, Maria Rosaria Cappelletti, Eva Ciruelos, Guy Jerusalem, Sherine Loi, Stephen B Fox, Daniele Generali
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study. Breast cancer research and treatment 184 (2) (2020)
Marianna Sirico, Ottavia Bernocchi, Navid Sobhani, Fabiola Giudici, Silvia Paola Corona, Claudio Vernieri, Federico Nichetti, Maria Rosa Cappelletti, Manuela Milani, Carla Strina, Valeria Cervoni, Giuseppina Barbieri, Nicoletta Ziglioli, Martina Dester, Giulia Valeria Bianchi, Filippo De Braud, Daniele Generali
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers 12 (11) (2020)
Navid Sobhani, Alberto D'Angelo, Xu Wang, Ken H Young, Daniele Generali, Yong Li
Mutant p53 as an Antigen in Cancer Immunotherapy. International journal of molecular sciences 21 (11) (2020)

Daniele Generali.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniele Generali